ArticleDermatology practical & conceptual2025

Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits.

Edoardo Cammarata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.